A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic Therapy
Status: | Completed |
---|---|
Conditions: | Arthritis, Rheumatoid Arthritis |
Therapuetic Areas: | Rheumatology |
Healthy: | No |
Age Range: | 18 - 100 |
Updated: | 7/2/2016 |
Start Date: | October 2013 |
End Date: | July 2015 |
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Investigate the Safety and Efficacy of ABT-494 Given With Methotrexate (MTX) in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Who Have Had an Inadequate Response or Intolerance to Anti-TNF Biologic Therapy
This is a multi center, randomized, double-blind, placebo-controlled phase 2 study in
subjects with moderately to severely active rheumatoid arthritis on background methotrexate
who have failed anti-Tumor Necrosis Factor (TNF) biologic therapy.
subjects with moderately to severely active rheumatoid arthritis on background methotrexate
who have failed anti-Tumor Necrosis Factor (TNF) biologic therapy.
Inclusion Criteria:
- Diagnosed with RA based on either the 1987-revised American College of Rheumatology
(ACR) classification criteria or the 2010 American College of Rheumatology/European
League against Rheumatism (ACR/EULAR) criteria for ≥ 3 months.
- Subjects must have been receiving oral or parenteral MTX therapy ≥ 3 months and on a
stable prescription of 7.5 to 25 mg/week for at least 4 weeks prior to initiating the
study drug. Subjects should also be on a stable dose of folic acid (or equivalent)
for at least 4 weeks prior to initiating the study drug. Subjects should continue
with their stable doses of MTX and folic acid throughout the study
- Subjects have been treated with 1 or more anti-TNF biologics (no maximum cap) for ≥ 3
months but continue to exhibit active RA, or had to discontinue due to intolerability
or toxicity. In addition, subjects with prior exposure to non-anti-TNF biologic(s)
(no maximum cap) (e.g., abatacept, rituximab, anakinra, or tocilizumab) are allowed.
- Have active RA as defined by the following minimum disease activity criteria:
>= 6 swollen joints (based on 66 joint counts) at Screening and Baseline, >= 6 tender
joints (based on 68 joint counts) at Screening and Baseline, hs-CRP > Upper Limit of
Normal (ULN) OR positive for both rheumatoid factor and anti-CCP antibody.
Exclusion Criteria:
- Prior exposure to Janus Activated Kinase (JAK) inhibitor (e.g. tofacitinib,
baricitinib)
- Pregnant or breastfeeding female
- Ongoing or active infection.
We found this trial at
65
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials